BIO International Convention 2026

The BIO International Convention 2026 will take place from June 22 to 25, 2026, at the San Diego Convention Center (USA). The event will be organized by the Biotechnology Innovation Organization (BIO).

With around 20,000 participants, the BIO International Convention is the world’s leading collaboration platform for the biotechnology and pharmaceutical industries. It brings together innovative startups, international investors, and global industry leaders, offering a unique space to network, share knowledge, and drive new projects forward.

It is the key event for the sector’s top decision-makers.

For the BIO International Convention 2026, the key focus areas include some of the fields that are transforming the biotechnology and healthcare sectors, such as artificial intelligence applied to health and digital health, cell and gene therapies, personalized medicine, and next-generation biotherapies. The program will also cover topics such as business development and investment, opportunities in emerging global markets, oncology, and rare diseases, as well as issues related to intellectual property, regulation, and commercialization. Additionally, key aspects such as translational research, patient access to treatments, and health equity will be addressed.

24/06/2026

11:00h-12:00h

The Future of Oncology Trials: Aligning Science, Regulation, and Investment in Overall Survival.

Ubicació: 32AB

Àmbit d’interès: Oncologia

Moderator: 

• Sarah Richards, Independent Science Journalist

Speakers:

• Jared Kelly, JD CEO, Oncolytics
• Ana Limon, PhD, Senior Vice President, Clinical Development and Medical Affairs, Oryzon Genomics
• Andres McAllister, MD, PhD, Chief Medical Officer, BioInvent International AB
• David J. Portman, MD, President of Oncology, LeonaBio

25/06/2026

10:15h-11:15h

Fast-tracking biotech innovation in Europe: how and when

Ubicació: 25BC

Àmbit d’interès: Oportunitats emergents en mercats globals

Moderator: 

• Maria Pilar Aguar Fernandez, MA. Directorate-General Research and Innovation, European Commission

Speakers:

• Xavier Cañas, Director of Academic & Commercial Clinical Research, Vall d'Hebron Institute of Research
  VHIR, Vall d'Hebron Barcelona Hospital Campus
• Carmen Hurtado del Pozo, PhD, Director, European Research, Breakthrough T1D
• Jean-David Malo, Directorate-General Research and Innovation, European Commission
• Jacqueline Phillips, Senior Director, Paediatric Product Development, Johnson & Johnson